Diet
UltraSound
Diabetes

Cancer & Biopsy
Germanium
Heart Disease
Free Radicals
IV Chelation Therapy

Vibrant Life Home Web
Family Of Three Chelation Formulas
MSM
Other VL Products
The Wednesday Letter
Frequently Asked Questions
Testimonials
Karl Loren Web


Shopping Cart

Separate Search Page
or search below


Navigation Help

Oral Chelation Therapy
Other

Ingredients
Technical
Write To Karl Loren Table Of Contents

27 Scientific Studies Relative To Protein and Glucose -- Diabetes

       

Search Results
Results for your query on September 23, 2000:
Words in title only: protein metabolism And glucose
Published in 1955 through 1999
Only select references with abstracts available
Show references published in English only
Show references pertaining to humans

Documents: 1 to 27 of 27

1

Top Of Menu

Hoffer LJ, et al; Dietary protein restriction alters glucose but not protein metabolism in non-insulin-dependent diabetes mellitus. (Metabolism, 1998 Sep, Abstract available) [MEDLINE]

2 Andersén E, et al; Effects of a high-protein and low-fat diet vs a low-protein and high-fat diet on blood glucose, serum lipoproteins, and cholesterol metabolism in noninsulin-dependent diabetics. (Am J Clin Nutr, 1987 Feb, Abstract available) [MEDLINE]
3 Solini A, et al; Protein metabolism in human obesity: relationship with glucose and lipid metabolism and with visceral adipose tissue. (J Clin Endocrinol Metab, 1997 Aug, Abstract available) [MEDLINE]
4 Shaw JH, et al; Metabolic intervention in surgical patients: the effect of alpha- or beta-blockade on glucose and protein metabolism in surgical patients receiving total parenteral nutrition. (Surgery, 1988 May, Abstract available) [MEDLINE]
5 Shaw JH, et al; An integrated analysis of glucose, fat, and protein metabolism in severely traumatized patients. Studies in the basal state and the response to total parenteral nutrition. (Ann Surg, 1989 Jan, Abstract available) [MEDLINE]
6 Linn T, et al; Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin-dependent diabetes mellitus. (J Clin Endocrinol Metab, 1996 Nov, Abstract available) [MEDLINE]
7 Zillikens MC, et al; Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls. (J Hepatol, 1993 Mar, Abstract available) [MEDLINE]
8 Long CL, et al; Glutamine supplementation of enteral nutrition: impact on whole body protein kinetics and glucose metabolism in critically ill patients. (JPEN J Parenter Enteral Nutr, 1995 Nov, Abstract available) [MEDLINE]
9 Fryburg DA, et al; Effects of epinephrine on human muscle glucose and protein metabolism. (Am J Physiol, 1995 Jan, Abstract available) [MEDLINE]
10

Menu Position #10

Shepherd PR, et al; Involvement of phosphoinositide 3-kinase in insulin stimulation of MAP-kinase and phosphorylation of protein kinase-B in human skeletal muscle: implications for glucose metabolism. (Diabetologia, 1997 Oct, Abstract available) [MEDLINE]

11 Hill MW, et al; Glucose metabolism and protein synthesis in stratified squamous epithelia from young and old mice. (Exp Gerontol, 1989, Abstract available) [MEDLINE]
12 Gore DC, et al; Except for alanine, muscle protein catabolism is not influenced by alterations in glucose metabolism during sepsis. (Arch Surg, 1995 Nov, Abstract available) [MEDLINE]
13 Flakoll PJ, et al; Protein and glucose metabolism during isolated closed-head injury. (Am J Physiol, 1995 Oct, Abstract available) [MEDLINE]
14 Newman E, et al; The effect of insulin on glucose and protein metabolism in the forearm of cancer patients. (Surg Oncol, 1992 Aug, Abstract available) [MEDLINE]
15 Passilta M, et al; Glucose metabolism, insulin-like growth factor-I, and insulin-like growth factor-binding protein-1 after alcohol withdrawal. (Alcohol Clin Exp Res, 1999 Mar, Abstract available) [MEDLINE]
16 Battezzati A, et al; Defective insulin action on protein and glucose metabolism during chronic hyperinsulinemia in subjects with benign insulinoma. (Diabetes, 1995 Jul, Abstract available) [MEDLINE]
17 Louard RJ, et al; Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle. (J Clin Invest, 1992 Dec, Abstract available) [MEDLINE]
18 Bresson JL, et al; Protein-metabolism kinetics and energy-substrate utilization in infants fed parenteral solutions with different glucose-fat ratios [see comments] (Am J Clin Nutr, 1991 Aug, Abstract available) [MEDLINE]
19 Larivière F, et al; Effects of dietary protein restriction on glucose and insulin metabolism in normal and diabetic humans. (Metabolism, 1994 Apr, Abstract available) [MEDLINE]
20

Menu Position #20

Franz MJ; Protein: metabolism and effect on blood glucose levels. (Diabetes Educ, 1997 Nov, Abstract available) [MEDLINE]

21 Mak RH, et al; The effect of a low protein diet with amino acid/keto acid supplements on glucose metabolism in children with uremia. (J Clin Endocrinol Metab, 1986 Oct, Abstract available) [MEDLINE]
22 Arslanian S, et al; Testosterone treatment in adolescents with delayed puberty: changes in body composition, protein, fat, and glucose metabolism. (J Clin Endocrinol Metab, 1997 Oct, Abstract available) [MEDLINE]
23 Castellino P, et al; Dissociation of the effects of epinephrine and insulin on glucose and protein metabolism. (Am J Physiol, 1990 Jan, Abstract available) [MEDLINE]
24 Dietz WH Jr, et al; Interrelationships of glucose and protein metabolism in obese adolescents during short-term hypocaloric dietary therapy. (Am J Clin Nutr, 1985 Sep, Abstract available) [MEDLINE]
25 Roy BD, et al; Effect of glucose supplement timing on protein metabolism after resistance training. (J Appl Physiol, 1997 Jun, Abstract available) [MEDLINE]
26 Zillikens MC, et al; Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls. (J Hepatol, 1993 Mar, Abstract available) [MEDLINE]
27 Rigalleau V, et al; Low protein diet in uremia: effects on glucose metabolism and energy production rate. (Kidney Int, 1997 Apr, Abstract available) [MEDLINE]


GTO  

Information on HealthGate.com is not a substitute for professional medical care or advice but should be used only as an aid in understanding current medical knowledge. A physician should always be consulted for any health problem or medical condition.

We subscribe to the HONcode principles
of the Health On the Net Foundation

Send comments to support@healthgate.com
Copyright © 2000 HealthGate® Data Corp. All rights reserved.

Record 1 from database: MEDLINE
Return To Top

Title
Dietary protein restriction alters glucose but not protein metabolism in non-insulin-dependent diabetes mellitus.
Author
Hoffer LJ; Taveroff A; Hamadeh MJ
Address
McGill Nutrition and Food Science Centre and the School of Dietetics and Human Nutrition, McGill University, Montreal, Quebec, Canada.
Source
Metabolism, 1998 Sep, 47:9, 1145-51
Abstract
We determined whether a customary diet high or low in protein (1) influences postabsorptive amino acid catabolism, nitrogen (N) balance, and hepatic glucose output (HGO) in normal subjects or patients with non-insulin-dependent diabetes mellitus (NIDDM) or (2) alters blood glucose levels in NIDDM. Eight normal young adults and five obese middle-aged persons with NIDDM consumed low-protein (0.8 g/kg lean body mass [LBM]) or high-protein (3.0 g/kg LBM) diets at maintenance energy for consecutive 7-day periods. Fasting and average blood glucose and N balance were measured daily. The level of dietary protein had no effect on the basal plasma leucine rate of appearance (Ra) or urinary 3-methylhistidine excretion in either subject group. Basal leucine oxidation (and by inference, whole-body amino acid catabolism) was reduced on the low-protein diet but basal HGO was not, and although exogenous glucose effectively suppressed HGO, it did not reduce leucine oxidation with either diet. After adaptation to the low-protein diet, N balance in both the normal and NIDDM subjects was close to zero. The low-protein diet reduced the fasting and daily blood glucose of the diabetic subjects by approximately 2 mmol/L (P < .05). We conclude that physiologic variation in dietary protein does not affect basal whole-body protein turnover or HGO in either normal young adults or obese middle-aged NIDDM subjects. However, protein restriction to the level of the average daily requirement significantly reduces postabsorptive and average daily blood glucose concentrations in persons with NIDDM.
Language of Publication
English
Unique Identifier
98421866

Return To Top


MeSH Heading (Major)
Diabetes Mellitus, Non-Insulin-Dependent|*ME; Dietary Proteins|*AD; Glucose|*ME; Proteins|*ME
MeSH Heading
Adult; Body Weight; Female; Human; Liver|ME; Male; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0026-0495
Country of Publication
UNITED STATES

Record 2 from database: MEDLINE
Return To Top

Title
Effects of a high-protein and low-fat diet vs a low-protein and high-fat diet on blood glucose, serum lipoproteins, and cholesterol metabolism in noninsulin-dependent diabetics.
Author
Andersén E; Hellström P; Kindstedt K; Hellström K
Address
 
Source
Am J Clin Nutr, 1987 Feb, 45:2, 406-13
Abstract
Six middle-aged patients with noninsulin-dependent diabetes and six normoglycemic control subjects were fed protein-rich and fat-poor (diet A) or protein-poor and fat-rich food (diet B). The patients were hyperglycemic, VLDL triglycerides levels were higher, and HDL cholesterol levels lower than corresponding findings in control subjects. Bile acid formation and biliary lipid composition did not differ between the two groups, but net steroid balance in the patients was elevated by a factor of approximately 2. A switch from diet A to diet B in control subjects was associated with an increase in HDL cholesterol and decreases in bile acid synthesis and net steroid balance. Lipoprotein pattern in the patients remained unchanged, and effects on total bile acid production and steroid balance were less consistent. It is suggested that the response in the patients reflected diabetes-associated abnormalities in lipid metabolism.
Language of Publication
English
Unique Identifier
87124596

Return To Top


MeSH Heading (Major)
Diabetes Mellitus, Non-Insulin-Dependent|BL/CO/*DH; Diabetic Diet|*; Dietary Fats|*AD; Dietary Proteins|*AD; Hyperlipoproteinemia|*DH/ET
MeSH Heading
Adult; Aged; Blood Glucose|ME; Cholesterol|ME; Comparative Study; Female; Human; Lipoproteins|BL; Male; Middle Age; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0002-9165
Country of Publication
UNITED STATES

Record 3 from database: MEDLINE
Return To Top

Title
Protein metabolism in human obesity: relationship with glucose and lipid metabolism and with visceral adipose tissue.
Author
Solini A; Bonora E; Bonadonna R; Castellino P; DeFronzo RA
Address
Department of Internal Medicine, University of Ferrara, Italy.
Source
J Clin Endocrinol Metab, 1997 Aug, 82:8, 2552-8
Abstract
It is controversial whether metabolic disorders of human obesity include protein metabolism. Even less information is available concerning the effect of fat distribution on protein metabolism. Therefore, a comprehensive evaluation of glucose, lipid, and protein metabolism was performed in 11 obese nondiabetic and 9 normal women whose body composition and regional fat distribution were determined. [1-14C]Leucine and [3-3H]glucose were infused in the postabsorptive state and during an euglycemic hyperinsulinemic (35-40 microU/mL) clamp combined with indirect calorimetry for assessment of leucine flux, oxidation, and nonoxidative disposal, glucose turnover and oxidation, and lipid oxidation. Fat-free mass (FFM) was estimated by a bolus of 3H2O. Subcutaneous abdominal and visceral adipose tissues were determined by nuclear magnetic resonance imaging. During the clamp, obese women had lower glucose turnover (4.51 +/- 0.41 vs. 6.63 +/- 0.40 mg/min.kg FFM; P < 0.05), with a defect in both oxidation (3.27 +/- 0.22 vs. 3.89 +/- 0.21) and nonoxidative disposal (1.24 +/- 0.27 vs. 2.74 +/- 0.41; P < 0.005), whereas lipid oxidation was higher during the clamp (0.49 +/- 0.15 vs. 0.17 +/- 0.09 mg/min.kg FFM). There was no difference in leucine flux (basal, 2.23 +/- 0.17 vs. 2.30 +/- 0.29; clamp, 2.06 +/- 0.19 vs. 2.10 +/- 0.24 mumol/min.kg FFM), oxidation (basal, 0.37 +/- 0.04 vs. 0.36 +/- 0.05; clamp, 0.34 +/- 0.04 vs. 0.39 +/- 0.06) and nonoxidative leucine disposal (basal, 1.86 +/- 0.17 vs. 1.94 +/- 0.26; clamp, 1.72 +/- 0.20 vs. 1.71 +/- 0.19) in the two groups. In obese women, basal leucine oxidation was directly related with glucose oxidation and inversely to lipid oxidation (both P < 0.05), whereas visceral adipose tissue was inversely related to leucine flux both in the basal state and during the clamp (P < 0.05). In conclusion, in human obesity, 1) rates of protein metabolism in the basal state and in the range of insulin concentrations encountered after a meal are normal; 2) protein oxidation is positively related to glucose oxidation and negatively related to lipid oxidation; and 3) visceral adipose tissue is inversely related to all parameters of protein metabolism.
Language of Publication
English
Unique Identifier
97397272

Return To Top


MeSH Heading (Major)
Blood Glucose|*ME; Lipids|*BL; Obesity|*ME; Proteins|*ME
MeSH Heading
Adipose Tissue; Adult; Body Composition; Calorimetry, Indirect; Fatty Acids, Nonesterified|BL; Female; Food; Glucose|ME; Glucose Clamp Technique; Human; Insulin|BL; Leucine|ME; Lipid Peroxidation; Oxidation-Reduction; Support, Non-U.S. Gov't; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0021-972X
Country of Publication
UNITED STATES

Record 4 from database: MEDLINE
Return To Top

Title
Metabolic intervention in surgical patients: the effect of alpha- or beta-blockade on glucose and protein metabolism in surgical patients receiving total parenteral nutrition.
Author
Shaw JH; Holdaway CM; Humberstone DA
Address
University Department of Surgery, Auckland Hospital, New Zealand.
Source
Surgery, 1988 May, 103:5, 520-5
Abstract
We performed a series of isotopic studies on the role of alpha- or beta-adrenergic activity in the regulation of glucose and protein metabolism in a group of surgical patients receiving total parenteral nutrition. We quantitated rates of glucose turnover and net protein breakdown by the primed constant infusion of 3H-glucose and 14C-urea, respectively. Basal measurements were first performed, and then the effect of either alpha- or beta-adrenergic blockade was assessed by means of the constant infusion of either phentolamine or propranolol. In addition, we assessed the effect of beta-stimulation by infusing the beta-agonist, salbutamol. The institution of alpha-adrenergic blockade did not significantly alter either the plasma glucose level or the rate of glucose production. However, the rate of net protein catabolism decreased significantly after alpha-adrenergic blockade. Before alpha-blockade the value for NPC was 0.88 +/- 0.27 gm/kg/day, and after alpha-blockade the corresponding value was 0.73 +/- 0.24 gm/kg/day (p less than 0.01). beta-Adrenergic blockade resulted in a decrease in the rate of glucose appearance from 38.2 +/- 6.1 mumol/kg/min to 35.1 +/- 5.7 mumol/kg/min, and the plasma glucose clearance increased from 5.0 +/- 0.8 ml/kg/min to 5.4 +/- 0.8 ml/kg/min. As a result of these changes the plasma glucose concentration decreased significantly (p less than 0.01) from 7.4 +/- 0.3 mumol/ml to 6.5 +/- 0.5 mumol/ml. beta-Adrenergic blockade did not significantly decrease the rate of net protein catabolism. beta-Stimulation with salbutamol resulted in a significant increase (p less than 0.05) in the rate of glucose production from 31.3 +/- 4.2 mumol/kg/min to 38.0 +/- 6.5 mumol/kg/min, and as a result the plasma glucose level increased significantly from 6.7 +/- 0.6 mumol/ml to 7.4 +/- 0.6 mumol/ml (p less than 0.04). We conclude from these studies that the role of the adrenergic nervous system in the promotion of endogenous glucose turnover in surgical patients receiving total parenteral nutrition is primarily a beta-adrenergic effect, whereas the promotion of protein catabolism is mainly an alpha-adrenergic effect.
Language of Publication
English
Unique Identifier
88205181

Return To Top


MeSH Heading (Major)
Adrenergic alpha-Antagonists|AD/*PD; Adrenergic beta-Antagonists|AD/*PD; Energy Metabolism|*; Glucose|*ME; Parenteral Nutrition, Total|*; Proteins|*ME; Surgical Procedures, Operative|*
MeSH Heading
Adult; Aged; Albuterol|AD/PD; Blood Glucose|AN; Female; Human; Hydrocortisone|BL; Infusions, Intravenous; Insulin|BL; Male; Middle Age; Support, Non-U.S. Gov't; Urea|UR

Publication Type
JOURNAL ARTICLE
ISSN
0039-6060
Country of Publication
UNITED STATES

Record 5 from database: MEDLINE
Return To Top

Title
An integrated analysis of glucose, fat, and protein metabolism in severely traumatized patients. Studies in the basal state and the response to total parenteral nutrition.
Author
Shaw JH; Wolfe RR
Address
University Department of Surgery, Auckland Hospital, New Zealand.
Source
Ann Surg, 1989 Jan, 209:1, 63-72
Abstract
A series of isotopic infusions were performed in 43 severely ill patients suffering from blunt trauma (mean injury severity score of 31). The patient data have been compared with data obtained from 32 normal volunteers, and in addition the metabolic response of the trauma patient to total nutritional support (TPN) has been assessed. The rate of VO2 was elevated in the trauma patients compared with that of the volunteers (160 mumol/kg/minute vs. 103 mumol/kg/minute). Glucose production was significantly increased in the patients compared with the volunteers (21 +/- 2 mumol/kg/minute vs. 14 +/- 1 mumol/kg/minute), but the trauma patients had an impaired capacity to directly oxidize plasma glucose. The percentage of glucose uptake oxidized in the volunteers was 36 +/- 2%, and the percentage of glucose uptake recycled was 10 +/- 1%. By contrast, in the trauma patients, 23 +/- 4% of the glucose uptake was directly oxidized, and 29 +/- 11% was recycled. The rate of glycerol turnover in the trauma patients (5.3 +/- 0.3 mumol/kg/minute) was significantly elevated compared with the volunteer value (2.2 +/- 0.1 mumol/kg/minute), and the basal rate of fat oxidation was twice as high in the patients as in the volunteers (2 mg/kg/minute vs. 1 mg/kg/minute). The rate of whole body protein catabolism was significantly higher in the patients (5.8 +/- 0.7 g/kg/day vs. 4.3 +/- 0.3 g/kg/day), and as a result, the rate of net protein catabolism was significantly elevated in the patients. The response to TPN (amino acids and a 50:50 mixture of glucose and fat) included an increase in the percentage of glucose uptake oxidized (up to 45 +/- 12%), a decrease in the oxidation of fat (up to 0.8 mg/kg/minute), and a significant increase in whole body protein synthesis (up to 6.1 +/- 1.1 g/kg/day) so that the rate of net protein loss was minimized but not prevented. (The rate of net protein catabolism during TPN was 1.3 +/- 0.5 g/kg/day.) There was no correlation between the injury severity score (ISS) and the degree of metabolic abnormality. The rate of NPC in the patients with ISS less than 20 was higher than in the volunteers (ISS = 0), but the values for NPC in patients with ISS 21-40, and ISS greater than 40 were virtually identical to the corresponding values in patients with ISS less than 20. It is concluded from these studies that: 1) Trauma patients have a high rate of VO2.(ABSTRACT TRUNCATED AT 250 WORDS)
Language of Publication
English
Unique Identifier
89087212

Return To Top


MeSH Heading (Major)
Basal Metabolism|*; Fats|*ME; Glucose|*ME; Parenteral Nutrition, Total|*; Proteins|*ME; Wounds, Nonpenetrating|*ME/TH
MeSH Heading
Adolescence; Adult; Calorimetry; Energy Intake; Evaluation Studies; Fatty Acids, Nonesterified|ME; Female; Human; Hydrocortisone|BL; Insulin|BL; Kinetics; Male; Middle Age; Oxidation-Reduction; Oxygen Consumption; Severity of Illness Index; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0003-4932
Country of Publication
UNITED STATES

Record 6 from database: MEDLINE
Return To Top

Title
Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin-dependent diabetes mellitus.
Author
Linn T; Geyer R; Prassek S; Laube H
Address
Diabetology and Metabolism Unit, Justus Liebig University, Giessen, Germany.
Source
J Clin Endocrinol Metab, 1996 Nov, 81:11, 3938-43
Abstract
Adult-onset insulin dependent diabetes mellitus (IDDM) is associated with significant residual insulin secretion. The process leading to the ultimate destruction of B cells may be influenced, among other factors, by the quality and amount of ingested protein. Using a standardized food questionnaire, we matched 13 individuals with normal protein (NP; 0.74 +/- 0.08 g/kg.day) and high protein (HP; 1.87 +/- 0.26 g/kg.day) intake from a sample of 117 newly diagnosed IDDM patients according to sex, age, body mass index, and energy intake. Nondiabetic control subjects were also selected. Dietary habits did not change significantly over an observation period of 1 yr. Glucagon-stimulated C peptide was significantly higher in the NP compared to the HP group (0.71 +/- 0.06 vs. 0.50 +/- 0.04 nmol/L; P < 0.002). NP food was associated with higher overall insulin sensitivity in both patients and nondiabetic subjects. Hepatic glucose output was significantly increased in individuals with HP intake [HP IDDM, 14.8 +/- 0.6 vs. NP IDDM, 12.7 +/- 0.7 (P < 0.01); HP control, 12.2 +/- 0.5 vs. NP control, 10.9 +/- 0.5 (P < 0.01 mumol/kg.min). Insulin-mediated suppression of hepatic glucose production was impaired in diabetic patients with high protein intake, but not in patients with normal protein diet. Gluconeogenesis estimated from 13C enrichment in breath and plasma was increased in individuals on a HP diet. We conclude that a NP diet is accompanied by delayed progression of the continuous loss of endogenous insulin in IDDM. This phenomenon is possibly due to decreased insulin demand on the B cells and/or reduced hepatic glucose production favoring enhanced insulin sensitivity.
Language of Publication
English
Unique Identifier
97082605

Return To Top


MeSH Heading (Major)
Diabetes Mellitus, Insulin-Dependent|*DH/ME/*PP; Dietary Proteins|*AD; Glucose|*ME; Insulin|*SE
MeSH Heading
Adult; Blood Glucose|ME; C-Peptide|ME; Diet Records; Female; Glucagon|ME/PD; Gluconeogenesis; Human; Liver|ME; Male

Publication Type
JOURNAL ARTICLE
ISSN
0021-972X
Country of Publication
UNITED STATES

Record 7 from database: MEDLINE
Return To Top

Title
Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls.
Author
Zillikens MC; van den Berg JW; Wattimena JL; Rietveld T; Swart GR
Address
Department of Internal Medicine II, University Hospital Dijkzigt, Rotterdam, The Netherlands.
Source
J Hepatol, 1993 Mar, 17:3, 377-83
Abstract
Nocturnal glucose administration might prevent gluconeogenesis and concomitant protein loss due to hepatic glycogen depletion. In this study the effects of nocturnal oral glucose supplements on nitrogen metabolism were investigated in 8 cirrhotic patients and in 8 healthy controls. During the night, either polymeric glucose was given or water as placebo. In the patients with cirrhosis on placebo, nitrogen balance was not different from controls: -63 +/- 8 vs. -55 +/- 4 mg N/kg b.wt./9 h (mean +/- SEM). Cirrhotic patients had increased nocturnal protein turnover rates (measured with 15N-glycine) and increased early morning levels of free fatty acids (FFA), lactate, insulin, glucagon and growth hormone. After glucose, nitrogen balance improved by 36% in the cirrhotic group, with a decrease in protein turnover rates and a decrease in plasma levels of beta-hydroxybutyrate, urea and glucagon. In the controls, glucose had no effects on nitrogen balance, on protein turnover or on the hormone levels, except for reduced FFA and ketone body levels. These data show that nocturnal calorie supplements improve nitrogen balance during the night in cirrhotic patients but not in healthy controls. Long interprandial intervals should be avoided in cirrhotic patients.
Language of Publication
English
Unique Identifier
93301428

Return To Top


MeSH Heading (Major)
Glucose|*AD; Liver Cirrhosis|*DT/ME; Liver Glycogen|*ME; Proteins|*ME
MeSH Heading
Administration, Oral; Adult; Aged; Drug Administration Schedule; Female; Human; Male; Middle Age; Nitrogen|ME/UR; Pancreatic Hormones|ME; Polymers; Reference Values; Somatotropin|ME

Publication Type
CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; JOURNAL ARTICLE
ISSN
0168-8278
Country of Publication
IRELAND

Record 8 from database: MEDLINE
Return To Top

Title
Glutamine supplementation of enteral nutrition: impact on whole body protein kinetics and glucose metabolism in critically ill patients.
Author
Long CL; Nelson KM; DiRienzo DB; Weis JK; Stahl RD; Broussard TD; Theus WL; Clark JA; Pinson TW; Geiger JW; et al
Address
Department of Research, Carraway Methodist Medical Center, Birmingham, Alabama 35234, USA.
Source
JPEN J Parenter Enteral Nutr, 1995 Nov, 19:6, 470-6
Abstract
BACKGROUND: Glutamine-supplemented parenteral nutrition has been reported to attenuate the early postoperative reduction in intracellular glutamine and improve protein synthesis and nitrogen balance. We investigated the effect of an enteral formula or protein and glucose kinetics and nitrogen balance in trauma patients. METHODS: The enteral formula (AlitraQ) provided a mean intake of 0.35 g of glutamine/kg body weight per day to 16 trauma patients and was compared with an isonitrogenous formula that provided a mean of 0.05 g of glutamine/kg body weight per day in 14 trauma patients. After 3 days of feeding, protein kinetics were measured using a 4-hour prime-continuous infusion of L-[1-13C]leucine. Glucose kinetics were measured during the same time interval using prime-continuous infusion of [U-14C]- and [6-3H]glucose. RESULTS: Nitrogen balance was not significantly different in the two groups. There were no significant differences in protein turnover, synthesis, and breakdown between the two groups. There were no significant differences in glucose turnover, oxidation, recycling, and percent of VCO2 from glucose oxidation between the two groups. CONCLUSIONS: Glutamine-enriched enteral formulas are well tolerated by the severely injured patient but provide no additional nutritional advantage compared with standard enteral formulas during the first 3 days of feeding immediately after trauma.
Language of Publication
English
Unique Identifier
96357432

Return To Top


MeSH Heading (Major)
Critical Illness|*; Enteral Nutrition|*; Glucose|AD/*ME; Glutamine|*AD; Proteins|*ME
MeSH Heading
Adult; Energy Intake; Female; Human; Kinetics; Male; Methylhistidines|UR; Middle Age; Nitrogen|ME; Oxidation-Reduction; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0148-6071
Country of Publication
UNITED STATES

Record 9 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Effects of epinephrine on human muscle glucose and protein metabolism.
Author
Fryburg DA; Gelfand RA; Jahn LA; Oliveras D; Sherwin RS; Sacca L; Barrett EJ
Address
Department of Internal Medicine, University of Virginia Health Science Center, Charlottesville 22908.
Source
Am J Physiol, 1995 Jan, 268:1 Pt 1, E55-9
Abstract
Systemic epinephrine infusion causes hypoaminoacidemia and inhibits whole body leucine flux (proteolysis) in humans. Its specific action on muscle protein is not known and is difficult to assess during systemic epinephrine infusions, which affect plasma insulin, amino acid, and free fatty acid concentrations. During a steady-state infusion of L-[ring-2,6-3H]phenylalanine, we examined the effect of locally infused epinephrine on the metabolism of protein and glucose in forearm muscle of 10 healthy human volunteers. During local epinephrine infusion, systemic concentrations of glucose, phenylalanine, insulin, and epinephrine were unchanged and lactate declined (P < 0.02). Compared with baseline, epinephrine induced significant increases in forearm blood flow (P < 0.01) and net lactate release (P < 0.001) and a decrease in glucose uptake (P < 0.01) at both 2 and 4 h. At 2 and 4 h phenylalanine release from muscle proteolysis was suppressed (P < 0.01), and at 4 h the net phenylalanine balance was less negative than baseline (P < 0.02), indicating an anticatabolic effect on muscle protein. We conclude that in human forearm muscle epinephrine, at physiological concentrations, has a catabolic effect on muscle glycogen but an anticatabolic action on muscle protein. The mechanism of this latter effect is not known.
Language of Publication
English
Unique Identifier
95142164

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Epinephrine|BL/*PD; Glucose|*ME; Muscle Proteins|*ME; Muscles|*ME
MeSH Heading
Adult; Female; Forearm|BS; Human; Insulin|BL; Lactates|BL/ME; Male; Osmolar Concentration; Phenylalanine|BL/PK; Regional Blood Flow|DE

Publication Type
JOURNAL ARTICLE
ISSN
0002-9513
Country of Publication
UNITED STATES

Record 10 from database: MEDLINE
Order full text for this document

Title
Involvement of phosphoinositide 3-kinase in insulin stimulation of MAP-kinase and phosphorylation of protein kinase-B in human skeletal muscle: implications for glucose metabolism.
Author
Shepherd PR; Nave BT; Rincon J; Haigh RJ; Foulstone E; Proud C; Zierath JR; Siddle K; Wallberg Henriksson H
Address
Department of Biochemistry, University College London, UK.
Source
Diabetologia, 1997 Oct, 40:10, 1172-7
Abstract
Isolated skeletal muscle from healthy individuals was used to evaluate the role of phosphoinositide 3-kinase (PI 3-kinase) in insulin signalling pathways regulating mitogen activated protein kinase (MAP-kinase) and protein kinase-B and to investigate whether MAP-kinase was involved in signalling pathways regulating glucose metabolism. Insulin stimulated glycogen synthase activity (approximately 1.7 fold), increased 3-o-methylglucose transport into human skeletal muscle strips (approximately 2 fold) and stimulated phosphorylation of the p42 ERK-2 isoform of MAP-kinase. This phosphorylation of p42 ERK2 was not blocked by the PI 3-kinase inhibitors LY294002 and wortmannin although it was blocked by the MAP-kinase kinase (MEK) inhibitor PD 98059. However, PD98059 (up to 20 micromol/l) did not block insulin activation of glycogen synthase or stimulation of 3-o-methylglucose transport. Wortmannin and LY294002 did block insulin stimulation of protein kinase-B (PKB) phosphorylation and stimulation of 3-o-methylglucose transport was inhibited by wortmannin (IC50 approximately 100 nmol/l). These results indicate that MAP-kinase is activated by insulin in human skeletal muscle by a PI 3-kinase independent pathway. Furthermore this activation is not necessary for insulin stimulation of glucose transport or activation of glycogen synthase in this tissue.
Language of Publication
English
Unique Identifier
98007754

Order full text for this document


MeSH Heading (Major)
p42 MAP Kinase|AI/AN/*ME; Enzyme Inhibitors|*PD; Glycogen Synthase|AI/*ME; Insulin|*PD; Muscle, Skeletal|DE/*EN/ME/PA; Proto-Oncogene Proteins|AI/*ME; 1-Phosphatidylinositol 3-Kinase|AI/*ME; 3-O-Methylglucose|AI/*ME
MeSH Heading
Adult; Androstadienes|PD; Chromones|PD; Comparative Study; Dose-Response Relationship, Drug; Flavones|PD; Human; Male; Morpholines|PD; Phosphorylation; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0012-186X
Country of Publication
GERMANY


Record 11 from database: MEDLINE
Order full text for this document

Title
Glucose metabolism and protein synthesis in stratified squamous epithelia from young and old mice.
Author
Hill MW; Karthigasan J
Address
Dows Institute for Dental Research, University of Iowa, Iowa City 52242.
Source
Exp Gerontol, 1989, 24:4, 331-40
Abstract
Glucose metabolism in regionally distinct epidermis and oral epithelia of young adult and aged mice was studied using 5-3H glucose and differentially labelled 14C-glucose. The results obtained with 3H-glucose indicate there is active utilization of glucose by all the epithelia examined. However, an enhanced utilization of glucose was observed in old ear epidermis when compared to that in young mice. The measurements of respiratory 14CO2 in the young and old epidermis indicated that aerobic glycolysis was significantly greater in ear epidermis and buccal epithelium from old than from young mice. Pentose phosphate activity was significantly reduced in palate epithelium from old animals when compared with that of young animals. Incorporation of radioactively labelled leucine and histidine revealed some regional differences between the epithelia examined. However, no age-associated differences were observed in any of the tissues. It is concluded that the observed metabolic changes reflect regionally specific adaptations to local factors rather than representing a programmed biological event.
Language of Publication
English
Unique Identifier
90060268

Order full text for this document


MeSH Heading (Major)
Aging|*ME; Epithelium|*ME; Glucose|*ME; Proteins|*BI
MeSH Heading
Animal; Epidermis|ME; Human; Mice; Mice, Inbred C57BL; Mouth Mucosa|ME; Rats; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0531-5565
Country of Publication
ENGLAND


Record 12 from database: MEDLINE
Order full text for this document

Title
Except for alanine, muscle protein catabolism is not influenced by alterations in glucose metabolism during sepsis.
Author
Gore DC; Jahoor F; Hibbert J; DeMaria EJ
Address
Department of Surgery, Medical College of Virginia, Richmond, USA.
Source
Arch Surg, 1995 Nov, 130:11, 1171-6; discussion 1176-7
Abstract
OBJECTIVE: To assess any relationship between hyperglycemia and muscle protein catabolism associated with critical illness. DESIGN: Cohort analytic study. SETTING: Clinical research center and intensive care unit of a university hospital. PARTICIPANTS: Six healthy volunteers and five patients with severe sepsis. INTERVENTIONS: Study subjects were given infusions of 6,6,d2 glucose and 15N lysine for 6 hours. After infusion of the stable isotopes for 2 hours (basal period), dichloroacetate, which accelerates pyruvate oxidation, was given (dichloroacetate period). Leg blood flow was measured by indocyanine green dye dilution, and femoral artery and vein substrate concentrations were quantitated. MAIN OUTCOME MEASURES: The metabolic rates of glucose production, oxidation, and clearance; the whole-body protein breakdown rate; and the net efflux of amino acids from the leg were determined. RESULTS: In comparison with the healthy volunteers, septic patients had significant elevations in glucose production, oxidation, and clearance, accelerated protein catabolism, and greater net peripheral efflux of amino acids. Dichloroacetate significantly decreased glucose production and increased the percentage of glucose directed toward oxidation in both healthy volunteers and septic patients. However, this dichloroacetate-induced perturbation of glucose utilization had no significant effect on whole-body protein breakdown or the efflux of specific amino acids from the leg except for alanine, whose net efflux doubled (P < or = .05). CONCLUSIONS: The findings of this study demonstrate a universal acceleration in the metabolic rates of both intermediary glucose metabolism and protein/amino acid catabolism during sepsis. Except for alanine, however, there appears to be no coupling between these two physiologic responses to sepsis.
Language of Publication
English
Unique Identifier
96050547

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Alanine|*ME; Glucose|*ME; Muscle Proteins|*ME; Sepsis|CO/*ME
MeSH Heading
Adult; Aged; Case-Control Studies; Cohort Studies; Female; Human; Hyperglycemia|CO/ME; Male; Middle Age

Publication Type
JOURNAL ARTICLE
ISSN
0004-0010
Country of Publication
UNITED STATES

Record 13 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Protein and glucose metabolism during isolated closed-head injury.
Author
Flakoll PJ; Wentzel LS; Hyman SA
Address
Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.
Source
Am J Physiol, 1995 Oct, 269:4 Pt 1, E636-41
Abstract
Patients with isolated closed-head injuries are characterized by excessive nitrogen loss, hyperglycemia, and increased caloric demand. However, the relative contributions of specific metabolic events such as protein breakdown and synthesis or glucose production and utilization to the physiological changes prevalent during isolated closed-head injury remains unestablished. By use of isotopic dilutions of L-[1-13C]leucine and D-[3-3H]glucose, components of protein and glucose metabolism were examined in patients with isolated closed-head injury (n = 7). Normal overnight-fasted volunteers (n = 8) were also studied as a reference point for comparison. Despite prevailing hyperinsulinemia (29 +/- 5 microU/ml), head-injured patients had elevated plasma leucine concentrations (183 +/- 22 vs. 144 +/- 8 mumol/l), whole body proteolysis (331 +/- 44 vs. 150 +/- 7 mg.kg-1.h-1), protein synthesis (248 +/- 38 vs. 126 +/- 11 mg.kg-1.h-1), and amino acid oxidation (84 +/- 11 vs. 23 +/- 3 mg.kg-1.h-1). Therefore nitrogen loss normally associated with isolated closed-head injury is primarily due to an increase in the rate of whole body proteolysis, with a greater proportion of the resultant amino acids being oxidized for energy. Furthermore, head-injured patients were hyperglycemic (6.7 +/- 0.3 mumol/l) with increased rates of glucose turnover (an estimate of production and utilization) compared with the controls (4.0 +/- 0.7 vs. 2.5 +/- 0.2 mg.kg-1.min-1). Hence, the